Nutraceuticals as potential therapeutic agents for colon cancer: a review

Palaniselvam Kuppusamy1, Mashitah M Yusoff1, Gaanty Pragas Maniam1

  • 1Mammalian Cell Technology Laboratory, Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang, Lebuhraya Tun Razak 26300, Gambang, Kuantan, Pahang, Malaysia.

Insights

Nutraceuticals, derived from natural sources, show promise in reducing colon cancer risk and progression. This review explores their medicinal importance in combating colorectal cancer.

Area of Science:

  • Oncology
  • Nutritional Science
  • Preventive Medicine

Background:

  • Colon cancer is a leading global health concern, with rising mortality linked to modern diets and lifestyles.
  • Increasing incidence necessitates novel, environmentally benign therapeutic strategies for colon cancer.
  • Nutraceuticals are emerging as key players in managing chronic diseases, including colon cancer.

Purpose of the Study:

  • To review the medicinal importance of nutraceuticals.
  • To discuss the potential of nutraceuticals in reducing colorectal cancer risk and slowing its progression.
  • To highlight nutraceuticals as natural, environmentally benign therapeutic options.

Main Methods:

  • Literature review of scientific studies on nutraceuticals and colon cancer.
  • Analysis of nutraceuticals derived from natural sources like plants, marine organisms, vegetables, and fruits.
  • Examination of molecular targets and mechanisms of action for nutraceuticals in cancer development.

Main Results:

  • Nutraceuticals demonstrate potential in mitigating colon cancer risk.
  • These natural compounds can influence various molecular pathways involved in cancer development.
  • Nutraceuticals show promise in slowing the progression of existing colon cancer.

Conclusions:

  • Nutraceuticals offer a valuable approach for reducing the risk of colorectal cancer.
  • Their natural origin and diverse mechanisms make them attractive therapeutic agents.
  • Further research into nutraceuticals can lead to innovative, eco-friendly colon cancer therapies.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
618
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
764